Part of the movement

We want to be a reflection of our customers and strongly believe in giving back to the community. We will be donating 1% of all sales (not profits) to The Cancer Research Institute. We may be a small business but even a small percentage can help make a difference and contribute to a larger cause.
Join us in making a difference. 

Donating to a Future Immune to Cancer 
The Cancer Research Institute is a 501(c)(3) non-profit organisation dedicated to harnessing the immune system's power to control and potentially cure all types of cancer. They fund the most innovative clinical and laboratory research around the world, support the next generation of the field's leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. 

What is Immunotherapy?
Immunotherapy, also known as immuno-oncology, is a form of cancer treatment that uses the power of the body’s own immune system to prevent, control, and eliminate cancer.

Immunotherapy can:
- Educate the immune system to recognize and attack specific cancer cells
- Boost immune cells to help them eliminate cancer
- Provide the body with additional components to enhance the immune response

Cancer immunotherapy comes in a variety of forms, including targeted antibodies, cancer vaccines, adoptive cell transfer, tumour-infecting viruses, checkpoint inhibitors, cytokines, and adjuvants. Immunotherapies are a form of biotherapy (also called biologic therapy or biological response modifier (BRM) therapy) because they use materials from living organisms to fight disease. Some immunotherapy treatments use genetic engineering to enhance immune cells’ cancer-fighting capabilities and may be referred to as gene therapies. Many immunotherapy treatments for preventing, managing, or treating different cancers can also be used in combination with surgery, chemotherapy, radiation, or targeted therapies to improve their effectiveness.

Your support of CRI directly impacts the discovery and development of powerful immunotherapies for all types of cancers—funding more breakthroughs and saving more lives.